약물전달 시스템 및 마이크로니들 패치 시장 예측(-2034년) : 약물전달 시스템 종류, 소재, 치료 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Drug Delivery Systems & Microneedle Patches Market is accounted for $3.4 billion in 2026 and is expected to reach $5.6 billion by 2034 growing at a CAGR of 6.5% during the forecast period. Drug Delivery Systems & Microneedle Patches involve advanced technologies designed to administer medicines into the body safely, efficiently, and precisely. Microneedle patches contain microscopic needles that penetrate the outer skin layer to deliver therapeutic substances with minimal discomfort. They are used for delivering vaccines, insulin, hormones, and various medications. Continuous improvements in material selection, needle structures, skin compatibility, and drug-release technologies are supporting the development of innovative delivery solutions for pharmaceutical, biotechnology, and medical applications.

According to the World Health Organization (WHO), its 2025 Global Vaccine Market Report covered 115 vaccine products across 207 countries and procurement channels, supplied by 137 manufacturers, highlighting the extensive global vaccine manufacturing and distribution ecosystem that supports demand for innovative drug delivery technologies.

Market Dynamics:

Driver:

Increasing demand for minimally invasive drug administration

Rising interest in less invasive medical procedures is supporting the development of advanced drug delivery technologies and microneedle patches. Many patients prefer these alternatives because they can minimize injection-related discomfort and make medication administration more convenient. Microneedle technology uses extremely small needles to transport medicines through the skin. This approach may improve treatment acceptance, encourage consistent medication use, and simplify healthcare delivery. Increasing applications in immunization, diabetes care, and long-term disease management are motivating pharmaceutical companies to expand their research and product development activities.

Restraint:

High development and manufacturing costs

Expensive research and production processes present a significant challenge for the development of drug delivery technologies and microneedle patches. Manufacturing these products involves specialized materials, sophisticated equipment, precise engineering, and comprehensive safety evaluations. Ensuring consistent needle quality, medication stability, and accurate drug administration can increase operational expenditure. Smaller businesses and emerging manufacturers may struggle to manage these investments while expanding production capacity. Consequently, elevated development and manufacturing expenses can affect product pricing, restrict accessibility, and delay wider commercialization across healthcare applications.

Opportunity:

Expansion of microneedle applications in vaccine delivery

Increasing demand for innovative immunization methods is opening new opportunities for microneedle patches and advanced drug delivery technologies. These products can administer vaccines through the skin using microscopic needles, potentially improving patient convenience and reducing discomfort associated with traditional injections. Their potential advantages in vaccine distribution, storage, and administration are encouraging pharmaceutical manufacturers to explore new applications. Ongoing research into microneedle-based immunization against infectious diseases is supporting product innovation and creating opportunities to improve vaccine accessibility across different healthcare settings.

Threat:

Competition from conventional drug delivery methods

Established medication administration methods create competitive challenges for the expansion of microneedle patches and advanced drug delivery systems. Conventional injections, oral medicines, and existing skin-based formulations benefit from recognized clinical performance, established production facilities, and regulatory acceptance. Healthcare professionals may remain cautious about adopting newer technologies until their safety, effectiveness, and economic advantages are demonstrated. Existing treatment practices and infrastructure further support traditional delivery methods. These factors may restrict market penetration and delay the broader acceptance of microneedle-based pharmaceutical products.

Covid-19 Impact:

The COVID-19 outbreak affected the Drug Delivery Systems & Microneedle Patches Market by accelerating interest in advanced vaccine administration and less invasive treatment technologies. The global vaccination requirements motivated pharmaceutical manufacturers and research organizations to explore microneedle patches for delivering vaccines more conveniently. Nevertheless, interruptions in supply chains, production activities, and clinical trials created temporary obstacles for product development. The pandemic demonstrated the value of accessible, scalable, and convenient medication delivery methods, encouraging further research and investment in innovative transdermal drug delivery technologies.

The injectable drug delivery systems segment is expected to be the largest during the forecast period

The injectable drug delivery systems segment is expected to account for the largest market share during the forecast period because they enable medicines to enter the body through controlled injection procedures. They are commonly utilized for administering vaccines, insulin, biological medicines, antibiotics, and other treatments requiring accurate delivery. Their use across healthcare facilities, emergency services, and long-term disease management highlights their clinical significance. Ongoing developments in injection devices, prefilled delivery solutions, and pharmaceutical formulations are improving administration convenience, treatment reliability, and the availability of injectable therapies across medical applications.

The homecare settings segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare settings segment is predicted to witness the highest growth rate, emerging as an expanding application area for drug delivery systems and microneedle patches due to the increasing preference for convenient healthcare services at home. These environments facilitate medication management for patients with chronic conditions, post-treatment recovery needs, and ongoing healthcare requirements. Advanced delivery technologies such as wearable medication devices, prefilled systems, and microneedle patches simplify treatment administration. Increasing acceptance of self-medication, digital health monitoring, and individualized treatment approaches is supporting the development and utilization of home-based drug delivery solutions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, through its developed healthcare infrastructure, established pharmaceutical sector, and continuous technological innovation. The region has a strong network of biotechnology companies, medical device manufacturers, and research organizations focusing on advanced medication delivery methods. Increasing utilization of biologics, vaccines, and minimally invasive treatments is supporting market development. Furthermore, substantial healthcare investments, supportive regulatory pathways, and expanding research activities are encouraging the development and commercialization of innovative drug delivery technologies across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by rising healthcare investments, expanding pharmaceutical industries, and improvements in medical infrastructure. Major markets, including China, India, Japan, and South Korea, are witnessing increasing research and development activities in advanced medication delivery technologies. Growing demand for minimally invasive treatments, increasing chronic disease cases, and greater awareness of innovative healthcare solutions are encouraging regional manufacturers to expand production and develop new drug delivery technologies.

Key players in the market

Some of the key players in Drug Delivery Systems & Microneedle Patches Market include 3M Company, Becton, Dickinson and Company, Corium, Inc., CosMED Pharmaceutical Co., Ltd., Kindeva Drug Delivery, LTS Lohmann Therapie-Systeme AG, Micron Biomedical, Inc., Microdermics Inc., NanoPass Technologies Ltd., Nitto Denko Corporation, Raphas Co., Ltd., SNvia Co., Ltd., Vaxxas Pty Ltd., Zosano Pharma Corporation, Debiotech S.A., Cutanos GmbH, QuadMedicine Inc. and AdminMed nanoBioSciences LLC.

Key Developments:

In January 2026, BD (Becton, Dickinson and Company) and Ypsomed are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak(TM) XtraFlow(TM) Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate(R) 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large-volume subcutaneous self-injections.

In May 2025, 3M has reached an agreement that resolves all legacy claims related to the Chambers Works site in Salem County, New Jersey, currently owned by The Chemours Company and, before that, by DuPont. In addition, the settlement extends to PFAS-related claims that the State of New Jersey and its departments have, or may in the future have, against 3M.

Delivery System Types Covered:

• Oral Drug Delivery Systems
• Injectable Drug Delivery Systems
• Transdermal Drug Delivery Systems
• Microneedle Patches
• Implantable Drug Delivery Systems
• Inhalation Drug Delivery Systems

Materials Covered:

• Polymer-based Systems
• Lipid-based Systems
• Metallic Microneedles
• Hydrogel-based Systems
• Biodegradable Systems

Therapeutic Applications Covered:

• Oncology
• Diabetes Management
• Cardiovascular Disorders
• Infectious Diseases & Vaccination
• Pain Management
• Dermatology & Cosmetic Applications

End Users Covered:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Research & Academic Institutes

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Drug Delivery Systems & Microneedle Patches Market, By Delivery System Type

• 5.1 Oral Drug Delivery Systems
• 5.2 Injectable Drug Delivery Systems
• 5.3 Transdermal Drug Delivery Systems
• 5.4 Microneedle Patches
• 5.5 Implantable Drug Delivery Systems
• 5.6 Inhalation Drug Delivery Systems

6 Global Drug Delivery Systems & Microneedle Patches Market, By Material

• 6.1 Polymer-based Systems
• 6.2 Lipid-based Systems
• 6.3 Metallic Microneedles
• 6.4 Hydrogel-based Systems
• 6.5 Biodegradable Systems

7 Global Drug Delivery Systems & Microneedle Patches Market, By Therapeutic Application

• 7.1 Oncology
• 7.2 Diabetes Management
• 7.3 Cardiovascular Disorders
• 7.4 Infectious Diseases & Vaccination
• 7.5 Pain Management
• 7.6 Dermatology & Cosmetic Applications

8 Global Drug Delivery Systems & Microneedle Patches Market, By End User

• 8.1 Hospitals & Clinics
• 8.2 Ambulatory Surgical Centers
• 8.3 Homecare Settings
• 8.4 Research & Academic Institutes

9 Global Drug Delivery Systems & Microneedle Patches Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 3M Company
• 12.2 Becton, Dickinson and Company
• 12.3 Corium, Inc.
• 12.4 CosMED Pharmaceutical Co., Ltd.
• 12.5 Kindeva Drug Delivery
• 12.6 LTS Lohmann Therapie-Systeme AG
• 12.7 Micron Biomedical, Inc.
• 12.8 Microdermics Inc.
• 12.9 NanoPass Technologies Ltd.
• 12.10 Nitto Denko Corporation
• 12.11 Raphas Co., Ltd.
• 12.12 SNvia Co., Ltd.
• 12.13 Vaxxas Pty Ltd.
• 12.14 Zosano Pharma Corporation
• 12.15 Debiotech S.A.
• 12.16 Cutanos GmbH
• 12.17 QuadMedicine Inc.
• 12.18 AdminMed nanoBioSciences LLC